Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
252.5500 5.50 (2.23%)
NSE Jun 27, 2025 15:31 PM
Volume: 936.2K
 

252.55
2.23%
Karvy
Marksans Pharma: Strong growth continues; Target revised upwardsMarksans Pharma is a finished dosage producing company (with increasing focus on soft gelatine dosage manufacturing) and with subsidiaries in UK and Australasia operating in OTC and Rx. It has manufacturing facilities in Goa (USFDA, UKMHRA and TGA approved) and Southport, UK (UKMHRA).
Marksans Pharma Ltd. has gained 58.80% in the last 1 Year
More from Marksans Pharma Ltd.
Recommended